the therapeutic effect of Shiwei Qingyang Decoction on Omicron variant of COVID-19 infectio
- Conditions
- Omicron variant of COVID-19 infection
- Registration Number
- ITMCTR2200006040
- Lead Sponsor
- Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Coronavirus infection (nucleic acid tests or antigen test was positive, CT value <40), mild or asymptomatic coronavirus carriers;
2. Entered the fangcang hospital which was taken over by Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine;
3. who have given informed consent and accept the treatment of Shiwei Qingyang Decoction;
4. aged from 18 to 75 years
Note: only those who meet the above 4 criteria can be included in this study.
1. unwilling to accept the treatment of Shiwei Qingyang Decoction;
2, unconsciousness, failure to express subjective discomfort symptoms and mental disorder patients;
3, accompanied by more than one severe secondary progressive malignancy or other severe wasting diseases;
4. Patients with severe symptoms of depression and anxiety;
5. Age <18 or age >75
Note: patients who met any of the above criteria were excluded.
Study & Design
- Study Type
- Treatment study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ucleic acid detection of COVID-19;
- Secondary Outcome Measures
Name Time Method